4.2 Article

Action of miR-133b Targeting Kinesin Family Member 15 on Astrocyte Proliferation and Apoptosis

期刊

出版社

AMER SCIENTIFIC PUBLISHERS
DOI: 10.1166/jbt.2021.2390

关键词

Astrocytes; miR-133b; Kif15; Cell Proliferation; Apoptosis

资金

  1. Medical and health science technology program of Zhejiang Province [2020KY1061]

向作者/读者索取更多资源

The research revealed that miR-133b plays a regulatory role in astrocyte proliferation and apoptosis by targeting down-regulated expression of Kif15 protein. Overexpression of miR-133b led to decreased cellular proliferation and increased apoptosis rates, possibly through down-regulating Kif15 expression.
To determine the effect of miR-133b targeting Kif15 on astrocyte proliferation and apoptosis and its mechanism, miR-133b mimics were transfected to astrocytes. qRT-PCR was applied to test miR-133b levels to verify the transfection effect, and MTT was applied to test the action of miR-133b overexpression on cellular proliferation activity. Flow cytometry was applied to test the action of miR-133b overexpression on the apoptosis rate. Western blot was adopted to detect miR-133b overexpression on cellular recombinant kinesin family member 15 (Kif15), Bcl2, and Bax protein. starBase online software forecasts exhibited that 3'UTR of Kif15 have miR-133b binding sites. The targeting association between miR-133b and Kif15 was verified using a double-luciferase reporter gene assay. By comparison with the miR-con group, there was a reduction in astrocyte absorption values and Bcl2 protein expression in the miR-133b group (P < 0.05) and an increase in the apoptosis rate and Bax protein expression level (P < 0.05). Kif15 was negatively regulated by miR-133b in astrocytes. The overexpression of Kif15 reversed the action of miR-133b on astrocyte proliferation and apoptosis. Overexpression of miR-133b probably inhibited the proliferative activity of astrocytes and induced their apoptosis by targeting down- regulated Kif15 expression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据